ISSN 2415-3060 (print), ISSN 2522-4972 (online)
  • 43 of 59
JMBS 2020, 5(5): 324–331

Effect of Exercise on Intestinal Microbium and Insulin Resistance in Person with Metabolic Syndrome

Hurenko O. O., Drozdovska S. B.

Metabolic syndrome is a cluster of cardiometabolic risk factors. They include obesity, dyslipidemia, hypertension, and insulin resistance. Central obesity and resistance to insulin, in particular, are recognized as causative factors, which form the development of metabolic syndrome. Metabolic syndrome is a progressive and genetically determined condition. The result of its progression is that carbohydrate, lipid and purine metabolism break down. The intestinal microbiome has a significant role in the pathogenesis of metabolic syndrome. One of the methods of influencing the micribiotic composition is the physical activity. The human intestinal microbiome is a complex ecosystem consisting not only of microorganisms, but also including bacteria, archaea, fungi and viruses. Biodiversity and the overall composition of the microbiota play a crucial role in maintaining normal homeostasis in the human body. With the recent advent of the possibility of studying the intestinal microbiome, the impact on its taxonomic composition and metabolism through exercise is the subject of scientific interest. Recent studies showed that the intestinal microbiota was directly involved in the formation of the metabolic syndrome. The function of the microbiome is just as important as the function of the "metabolic organs" that affect energy homeostasis and control body weight. In addition, changes in the intestinal microbiotic composition lead to increased intestinal permeability, endotoxemia, which plays a role in the development of chronic inflammation in the host, contributing to the development of metabolic syndrome and related chronic metabolic diseases. Intestinal microbiota in its own right is injected into the development of systemic inflammation in obesity, such a rank, inappropriate insertions in development or regression of insulin resistance, and hyperglycemia in metabolic syndrome. Physical activity can affect not only the composition of the microbial composition, but also the metabolic activity of the intestinal microbiome. The health-improving effect of physical exercises is connected with their ability to change the composition of an intestinal microbiota. Studies involving professional athletes and a specially selected control group indicated that athletes had a lower pro-inflammatory status and a high degree of bacterial diversity. Due to this, there is a positive dynamics of improving carbohydrate metabolism and the impact on the course of pathological processes associated with the metabolic syndrome, through the introduction of regular physical activity. Conclusion. The literature review presents data on the metabolic syndrome, its pathogenesis and components of the spectrum of development of metabolic disorders. We also analyzed material on influence of gut microbiota on development of metabolic disturbances and inreraction of structure of a microbiotic composition with physical exercises

Keywords: microbiome, metabolic syndrome, insulin resistance, physical activity, obesity

Full text: PDF (Ukr) 289K

  1. Festi D, Schiumerini R, Eusebi LH, Marasco G, Taddia M, Colecchia A. Gut microbiota and metabolic syndrome. World J Gastroenterol. 2014; 20(43): 16079-16094.
  2. Saklayen MG. The Global Epidemic of the Metabolic Syndrome. Curr Hypertens Rep. 2018; 20(2): 12.
  3. Srikanthan K, Feyh A, Visweshwar H, Shapiro JI, Sodhi K. A systematic review of metabolic syndrome biomarkers: a panel for early detection, management, and risk stratification in the West Virginia population. Int J Med Sci. 2016; 13 (1): 25-38.
  4. Chazova IE, Mychka VB. Metabolicheskiy sindrom [Metabolic syndrome]. Kardiovaskulyarnaya terapiya i profilaktika. 2003; (3): 32-38. [Russian]
  5. Mychka VB, Bogieva RM, Chazova IE. Akrobaza. Credstvo profilaktiki mnozhestvennykh serdechno-sosudistykh faktorov riska metabolicheskogo sindroma [Akrobaza. A drug for the prevention of multiple cardiovascular risk factors for metabolic syndrome]. Klin farmakol i ter. 2003; 12: 80-83. [Russian]
  6. Schinner S, Scherbaum WA, Bornstein SR, Barthel A. Molecular mechanisms of insulin resistance. Diabet Med. 2005; (22): 674–682.
  7. Yudin SM, Egorova AM, Makarov VV. Analiz mikrobioty cheloveka. rossiyskiy i zarubezhnyy opyt [Analysis of the human microbiota. Russian and foreign experience]. Mezhdunarodnyy zhurnal prikladnykh i fundamentalnykh issledovaniy. 2018; 11: 175-180. [Russian]
  8. Sheybak VM. Mikrobiom kishechnika cheloveka i ego vliyanie na metabolizm [The human gut microbiome and its effect on metabolism]. Zhurnal GrGMU. 2015; 50: 37-43. [Russian]
  9. Lin HV, Frassetto A, Kowalik EJ, Nawrocki AR, Lu MM, Kosinski JR, et al. Butyrate and propionate protect against diet-induced obesity and regulate gut hormones via free fatty acid receptor 3-independent mechanisms. PLoS One. 2012; 7(4): e35240.
  10. Kolyada A, Syzenko G, Moseyko V. Svyaz mezhdu indeksom massy tela i sootnosheniem Firmicutes/Bacteroidetes u vzroslogo naseleniya Ukrainy [Relationship between body mass index and the Firmicutes / Bacteroidetes ratio in the adult population of Ukraine]. BMC Microbiol. 2017; 120. [Russian]
  11. Kodrova AD, Shishkin AN. Rol kishechnoy mikrobioty v razvitii metabolicheskogo sindroma [The role of gut microbiota in the development of metabolic syndrome]. Eksperimentalnaya i klinicheskaya gastroenterologiya. 2019; 12: 101-8. [Russian]
  12. Turnbow PJ, Hamadi M, Yatsunenko T, Kantarel BL, Duncan A, Lei RE, et al. The gut microbiome in obese and thin twins. Nature. 2009; 457(7228): 480-484.
  13. Plotnikova EYu, Krasnov OA. Metabolicheskiy sindrom i kishechnaya mikroflora: chto obshchego? [Metabolic syndrome and intestinal microflora: what is common?]. Eksperimentalnaya i klinicheskaya gastroenterologiya. 2014; 12: 65. [Russian]
  14. Blekhman R, Goodrich JK, Huang K, Sun Q, Bukowski R, Bell JT, et al. Genetic variability in hosts affects the composition of the microbiome in different parts of the human body. Genome Biol. 2015; 16(1): 191.
  15. O'Sullivan O, Cronin O, Clarke SF, Murphy EF, Molloy MG, Shanahan F, et al. Exercise and microbiota. Intestinal microbes. 2015; 6(2): 131-136.
  16. Balducci S, Zanuso S, Nicolucci A, Fernando F, Cavallo S, Cardelli P, et al. Anti-inflammatory effect of exercise training in subjects with type 2 diabetes and the metabolic syndrome is dependent on exercise modalities and independent of weight loss. Nutr Metab Cardiovask Dis. 2010; 20(8): 608-17.
  17. Dealey-Conwright CM, Courneya KS, Demark-Wahnefried W, et al. Effects of aerobic and resistance exercise on metabolic syndrome, sarcopenic obesity, and circulating biomarkers in overweight or obese breast cancer survivors: a randomized controlled trial. J Clin Oncol. 2018; 36(9): 875-883.
  18. Meneses-Echávez JF, Correa-Bautista JE, González-Jiménez E, Schmidt Río-Valle J, Elkins MR, Lobelo F, et al. The Effect of Exercise Training on Mediators of Inflammation in Breast Cancer Survivors: A Systematic Review with Meta-analysis. Cancer Epidemiol Biomarkers Prev. 2016; 25(7): 1009-1017.
  19. Roberts CK, Hevener AL, Barnard RJ. Metabolic syndrome and insulin resistance: underlying causes and modification by exercise training. Comprehensive Physiology. 2013; 3(1): 1-58.
  20. Fernandez DM, Clemente JC, Giannarelli C. Physical Activity, Immune System, and the Microbiome in Cardiovascular Disease. Front Physiol. 2018; 9: 763.
  21. Allen JM, Meiling J, Kohers J, Salmonson S, Fryer JD, Nehra W, et al. Exercise training-induced modification of the gut microbiota persists after microbiota colonization and attenuates the response to chemically-induced colitis in gnotobiotic mice. Gut Microbes. 2018 Mar 4; 9(2): 115-130.
  22. Scheiman J, Luber JM, Chavkin TA, MacDonald T, Tung A, Pham L-D, et al. Meta-omics analysis of elite athletes identifies a performance-enhancing microbe that functions via lactate metabolism. Nat Med. 2019; 25(7): 1104-1109.